The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure.

Vasc Health Risk Manag · 2006 · PMC1994002 · PMID 17319457

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, the mortality difference between the metoprolol or carvedilol group in the subgroup of patients with diabetes, which comprised 24% of the patients in either arm, did not reach statistical significance (hazard ratio [HR] 0.85, 95% CI, 0.69–1.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.